December 2012 FDA Recall Drug by Matrixx Initiatives Inc
D-155-2013 - Microbial Contamination of Non-Sterile Products

This Class I drug recall was voluntarily initiated by Matrixx Initiatives Inc on December 18, 2012 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-155-2013

Reason for Recall
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Initiated
12-18-2012
Reported
02-13-2013
Quantity
46,752 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Matrixx Initiatives Inc
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Batch or Lot Expiration Information

Lot# 2J23, Exp 09/15